Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(305 ILCS 5/5-5.24a) (Text of Section from P.A. 103-593) Sec. 5-5.24a. Remote ultrasounds and remote fetal nonstress tests; reimbursement. (a) Subject to federal approval, for dates of service beginning on and after January 1, 2025, the Department shall reimburse for remote ultrasound procedures and remote fetal nonstress tests when the patient is in a residence or other off-site location from the patient's provider and the same standard of care is met as would be present during an in-person visit. (b) Remote ultrasounds and remote fetal nonstress tests are only eligible for reimbursement when the provider uses digital technology: (1) to collect medical and other forms of health data |
| from a patient and to electronically transmit that information securely to a health care provider in a different location for interpretation and recommendation;
|
|
(2) that is compliant with the federal Health
|
| Insurance Portability and Accountability Act of 1996; and
|
|
(3) that is approved by the U.S. Food and Drug
|
|
(c) A fetal nonstress test is only eligible for reimbursement with a place of service modifier for at-home monitoring with remote monitoring solutions that are cleared by the U.S. Food and Drug Administration for on-label use for monitoring fetal heart rate, maternal heart rate, and uterine activity.
(d) The Department shall issue guidance to implement the provisions of this Section.
(Source: P.A. 103-593, eff. 6-7-24.)
(Text of Section from P.A. 103-870)
(This Section may contain text from a Public Act with a delayed effective date)
Sec. 5-5.24a. Coverage for at-home pregnancy tests. Beginning January 1, 2025, the medical assistance program shall provide coverage for at-home, urine-based pregnancy tests that are ordered directly by a clinician or furnished through a standing order for patient use, regardless of whether the tests are otherwise available over the counter. The coverage required under this Section is limited to a multipack, as defined by the Department, of at-home, urine-based pregnancy tests every 30 days.
(Source: P.A. 103-870, eff. 1-1-25.)
|
